12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga·03/27/2026 12:05:41
Listen to the news
Gainers
Pomdoctor (NASDAQ:POM) shares rose 33.0% to $0.36 during Friday's pre-market session. The market value of their outstanding shares is at $32.2 million.
OnKure Therapeutics (NASDAQ:OKUR) shares increased by 19.17% to $5.47. The company's market cap stands at $62.7 million.
GlucoTrack (NASDAQ:GCTK) shares rose 17.42% to $1.28.
Lantern Pharma (NASDAQ:LTRN) stock moved upwards by 12.44% to $2.35. The market value of their outstanding shares is at $23.3 million.
Rocket Pharmaceuticals (NASDAQ:RCKT) shares increased by 11.3% to $5.22. The company's market cap stands at $509.1 million.
ADMA Biologics (NASDAQ:ADMA) shares increased by 10.73% to $9.18. The market value of their outstanding shares is at $1.9 billion.
Losers
ENDRA Life Sciences (NASDAQ:NDRA) shares fell 12.4% to $4.02 during Friday's pre-market session. The company's market cap stands at $5.3 million.
Universe Pharmaceuticals (NASDAQ:UPC) shares fell 10.26% to $2.1. The market value of their outstanding shares is at $1.3 million.
Acumen Pharmaceuticals (NASDAQ:ABOS) stock declined by 10.2% to $2.29. The market value of their outstanding shares is at $154.4 million. As per the news, the Q4 earnings report came out yesterday.
Quoin Pharmaceuticals (NASDAQ:QNRX) shares decreased by 9.99% to $6.81. The market value of their outstanding shares is at $12.2 million. The company's, Q4 earnings came out yesterday.
Zenas BioPharma (NASDAQ:ZBIO) stock declined by 9.93% to $19.96. The company's market cap stands at $1.2 billion.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure. Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.